Entering 2025, only nine countries have fully legalized recreational cannabis at the national level — Uruguay, Georgia, South Africa, Canada, Mexico, Malta, Thailand, Luxembourg and Germany — with Germany’s April 2024 law the most consequential addition to that list. Everywhere else the picture is a patchwork of medical-only access, decriminalization and outright prohibition. If you want a clear read on where cannabis stands as the year begins, here is the global snapshot, the numbers behind it, and the changes worth watching.
The nine countries where recreational cannabis is legal
Full national legalization is still the exception, not the rule. As 2025 opens, these are the countries that have legalized adult recreational use, in the order they did it: Uruguay (2013), Georgia (2018), South Africa (2018), Canada (2018), Mexico (2021), Malta (2021), Thailand (2022), Luxembourg (2023) and Germany (2024). Their models differ enormously — Uruguay and Canada run licensed commercial sales, Malta and Germany rely on nonprofit cannabis clubs, and Georgia and South Africa allow private use but ban sales. That distinction between “legal to use” and “legal to buy” is the single most important thing to understand about the global map.
Germany reset the European conversation
Germany’s Cannabis Act, in force since 1 April 2024, made the EU’s largest economy the biggest country yet to legalize adult use. Adults may carry up to 25 grams in public, keep up to 50 grams at home, grow three plants, and join nonprofit cultivation associations capped at 500 members. There are no dispensaries — supply flows through home-grow and clubs — but the symbolic weight is huge: when Germany moved, every other European capital had to take the question seriously. Watch our International desk for how the German rollout develops through 2025.
The Netherlands finally tackles its “back-door” problem
The country synonymous with cannabis tolerance is, ironically, not fully legal. For decades Dutch coffeeshops could sell cannabis at the “front door” while wholesale supply at the “back door” stayed illegal. That contradiction is now being tested: the government’s closed coffee-shop chain experiment — a regulated, legal supply trial across ten municipalities — is set to enter its main phase in April 2025. If it works, it could become a template for regulating supply without full commercial legalization.
The United States: the world’s biggest market, still federally illegal
Cannabis remains illegal under US federal law, yet 24 states plus Washington, D.C. allow adult recreational use entering 2025, and the large majority of states permit medical cannabis. This patchwork has produced the world’s largest market — roughly a $30 billion industry, with projections of $58–72 billion by the end of the decade. Federal reforms on rescheduling and banking access remain unresolved, which keeps the American market fragmented. Follow the state-by-state fights in our USA section.
Asia and the risk of reversal
Asia offers the year’s biggest wildcard. Thailand stunned the region by decriminalizing cannabis in 2022 and unleashing a fast-growing dispensary economy — but political pressure to tighten the rules has been building, and the framework’s future is uncertain as 2025 begins. It is a live reminder that legalization can move backward as well as forward. Elsewhere in the region, Japan maintains strict prohibition while carving out a narrow legal path for CBD, and most of Asia keeps some of the world’s toughest cannabis penalties on the books.
Latin America and Africa: pioneers and slow movers
Latin America produced the world’s first legalizer, Uruguay, and its most populous court-driven reform, Mexico, where the Supreme Court decriminalized adult use even as comprehensive legislation lagged. South Africa’s Constitutional Court legalized private adult use and cultivation in 2018, making it the continent’s most notable case, while other African nations have focused on licensing cannabis for medical export rather than domestic use. Compare these approaches with the mature market next door in our Canada coverage.
Medical access is spreading fastest of all
Step back from recreational law and the map looks far more permissive: more than 50 countries now allow some form of medical cannabis, from the UK, Germany and Italy to Australia, Israel and much of Latin America. For patients and travelers, that means the practical question is rarely a simple “legal or illegal,” but “legal for whom, in what form, and with what paperwork.” International trade in medical cannabis — led by producers in Canada and increasingly Europe — is one of the industry’s quietest but fastest-growing stories, tracked by policy groups like IDPC.
Why the global count keeps changing
Ask three sources how many countries have “legalized” cannabis and you may get three different answers, because they are measuring different things. Some counts include decriminalization — where possession is no longer a crime but sales stay illegal — while stricter counts only include nations with fully regulated commercial markets. Court-driven reforms add more confusion: in Mexico and South Africa, judges legalized personal use years before legislators wrote detailed rules, leaving a gap between what is technically legal and what is practically available. Add the difference between medical and recreational access, and it becomes clear why the “number” of legal countries is less useful than understanding each country’s specific model. When you read that cannabis is “legal” somewhere, the real questions are always: legal to use, to grow, or to buy — and for whom?
What to watch in 2025
Several storylines will shape the year. Germany’s rollout faces its first real stress test as clubs scale up and political opponents push back, so expect a running debate over whether the model expands toward licensed sales or gets reined in. The Dutch supply-chain experiment launches its main phase in the spring, and its results will influence how other European governments think about regulating wholesale. Thailand’s status is the region’s biggest question mark, with reform proposals that could narrow its market toward medical use. In the United States, the long-running push to reschedule cannabis and ease banking restrictions remains unresolved and politically charged. And the quiet expansion of medical-cannabis trade — new import approvals across Europe and beyond — will keep reshaping the industry even where recreational law stands still. For the science and safety questions underneath these debates, see our Learn section.
The bottom line for 2025
Entering 2025, cannabis policy is liberalizing but unevenly and never permanently: nine countries have full recreational legalization, Germany has reset Europe’s debate, the Netherlands is fixing its supply gap, the US remains a fragmented giant, medical access keeps spreading, and Asia shows that reforms can reverse. The throughline is simple — laws vary enormously and change often, so treat any status as a snapshot in time and always verify local rules before you buy, carry, grow or travel with cannabis. This article is informational, for adults of legal age; verify local legality before acting on it.


